Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1999;99:135-142

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelley, S. T.
Right arrow Articles by Edmunds, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelley, S. T.
Right arrow Articles by Edmunds, L. H., Jr
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Acute myocardial infarction

(Circulation. 1999;99:135-142.)
© 1999 American Heart Association, Inc.


Basic Science Reports

Restraining Infarct Expansion Preserves Left Ventricular Geometry and Function After Acute Anteroapical Infarction

Scott T. Kelley, MD; Ramin Malekan, MD; Joseph H. Gorman, III, MD; Benjamin M. Jackson, MS; Robert C. Gorman, MD; Yasuyuki Suzuki, MD; Theodore Plappert, CVT; Daniel K. Bogen, MD, PhD; Martin G. St. John Sutton, MBBS, FRCP; L. Henry Edmunds, Jr, MD

From the Departments of Surgery and Medicine, School of Medicine and Department of Bioengineering, University of Pennsylvania, Philadelphia, Pa.

Correspondence to Dr L. Henry Edmunds, Jr, Department of Surgery, 6 Silverstein, Hospital of the University of Pennsylvania, Philadelphia, PA 19104. E-mail hedmunds{at}mail.med.upenn.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Expansion of an acute myocardial infarction predicts progressive left ventricular (LV) dilatation, functional deterioration, and early death. This study tests the hypothesis that restraining expansion of an acute infarction preserves LV geometry and resting function.

Methods and Results—In 23 sheep, snares were placed around the distal left anterior descending and second diagonal coronary arteries. In 12 sheep, infarct deformation was prevented by Marlex mesh placed over the anticipated myocardial infarct. Snared arteries were occluded 10 to 14 days later. Serial hemodynamic measurements and transdiaphragmatic quantitative echocardiograms were obtained up to 8 weeks after anteroapical infarction of 0.23 of LV mass. In sheep with mesh, circulatory hemodynamics, stroke work, and end-systolic elastance return to preinfarction values 1 week after infarction and do not change subsequently. Ventricular volumes and ejection fraction do not change after the first week postinfarction. Control animals develop large anteroapical ventricular aneurysms, increasing LV dilatation, and progressive deterioration in circulatory hemodynamics and ventricular function. At week 8, differences in LV end-diastolic pressure, cardiac output, end-diastolic and end-systolic volumes, ejection fraction, stroke work, and end-systolic elastance are significant (P<0.01) between groups.

Conclusions—Preventing expansion of acute myocardial infarctions preserves LV geometry and function.


Key Words: ventricles • remodeling • myocardial infarction


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Many variables affect ventricular remodeling after acute myocardial infarction. Size, transmurality, and infarct location are major variables1–4; loading conditions, previous scar, revascularization of occluded vessels,5 and ACE inhibitors6 are among other important variables. Nearly 70% of all infarctions are transmural,7 {approx}54% are anterior,7 and 35% to 42% of anterior infarctions develop slippage between myocytes8 to produce infarct expansion and thinning.1 2 3 4 8 Ventricular dilatation ceases after a few days in well-compensated hearts with small, minimally expansive infarcts.9 In patients with expanding infarctions and more severe left ventricular (LV) dysfunction, the prognosis is ominous,1 2 4 9 10 because progressive LV dilatation and functional deterioration continue for weeks, months, and even years.2 4 10 11

Little is known of the material properties of healing myocardial infarctions,12 yet relative stiffness of the healing infarct influences mechanical forces affecting ventricular remodeling and performance.13 14 On the basis of infarct fibrosis, hydroxyproline content, and uniaxial stress extension studies,15 clinicians generally conclude that infarcts stiffen. However, this conclusion is inconsistent with the natural history of expanding infarctions2 3 4 9 10 11 and is not confirmed by biaxial stress extension studies of ovine infarctions.12 Mathematical models predict preservation of LV shape and resting function by preventing infarct expansion,13 14 but this prediction has not been tested in sophisticated finite-element models or demonstrated by serial measurements of postinfarction ventricular function. This study tests the hypothesis that restraining infarct expansion preserves ventricular geometry and resting function in a sheep model of acute anteroapical infarction that consistently progresses to LV aneurysm.16


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Surgical Protocol
Twenty-three healthy, Dorsett hybrid sheep were induced, intubated, anesthetized with isoflurane 1.5% to 2%, and ventilated with oxygen (Drager anesthesia monitor, North American Drager). All animals received glycopyrrolate 0.4 mg IV and cefazolin 1 g IV. Animals were treated in compliance with the Guide for the Care and Use of Laboratory Animals (NIH publication No. 85-23) as revised in 1985.

By use of aseptic technique, polypropylene snares were placed around the homonymous (designated LAD in this article) and second diagonal (D2) coronary arteries {approx}40% from the apex via left anterolateral thoracotomy.16 An ultrasonic flow probe (Transonic Systems, Inc) was placed around the aortic root. Two epicardial pacemaker wires were sewn to the right atrium. Group assignment was random; 11 animals served as controls (group 1). In 12 animals (group 2), Marlex mesh, a nondistensible, monofilament, knitted polypropylene mesh used for hernia repair, was sutured over the precise location of the expected anteroapical infarction of 0.23 of LV mass.16 The wound was closed, and the animals recovered.

Baseline Data
After 10 to 14 days, sheep were anesthetized with isoflurane 1% to 2%, intubated, and placed supine. Surface ECGs and arterial blood pressure were monitored continuously. A Swan-Ganz catheter (131h-7Fr Baxter Healthcare Corp) was introduced via the left internal jugular vein. A high-fidelity pressure transducer (Spc-350, Millar Instruments Inc) was inserted from the femoral artery into the LV (Hewlett-Packard 78534c monitor). Animals were disconnected from the ventilator, and the heart was atrially paced at 120 bpm for all measurements and echocardiograms.

Echocardiography
Subdiaphragmatic 2-dimensional echocardiographic images were obtained through a sterile, midline laparotomy with a 5-MHz. probe (Hewlett Packard 77020A) and were recorded on 0.5-in videotape at 30 Hz (Panasonic AG-6300 VHS Recorder, Matsushita Electric Industries Co Ltd). LV short-axis images at 3 levels (at the tips of the papillary muscles, at the bases of the papillary muscles, and at the apex) and 2 orthogonal long-axis views were obtained. As the LV aneurysm developed, the ventricular long axis angulated; therefore, the apical short-axis image was not always parallel to other short-axis images. LV apical long-axis views were used to calculate LV cavity volumes by biplane Simpson's rule.17

In addition, serial echocardiographic measurements were made of LV cavity diameter (at the tips of the papillary muscle) and LV long-axis cavity length to assess LV cavity shape (defined as the ratio of the short axis to long axis) at all time points in all animals. LV wall thickness was measured from short-axis images at the level of the papillary muscle bases at baseline and in infarct and remote zones at end diastole and end systole. Wall thickness was also measured in the apical short axis at 8 weeks. Myocardial infarct length was measured as the length of LV cavity perimeter that was either akinetic or dyskinetic (A/D); this A/D length as a percentage of the total cavity perimeter was calculated.9 Last, the length of cavity perimeter from the insertion of the aortic valve leaflets to the edge of the A/D segment in the anterior wall was measured immediately after infarction through 8 weeks.

Stroke Work
LV stroke work (SW) was measured from simultaneous measurements of stroke volume and LV pressure18: SW (ergs)=LVA (mm Hg–beat)xSV (mL/beat)x1330, where LVA is the area under the LV pressure trace, SV is stroke volume as determined by the aortic flow probe, and beat is time in seconds. Measurements were repeated 5 times; means were used for subsequent analyses.

Slope of the Stroke Work–LV End-Diastolic Pressure Relationship
A 50-mL Fogarty catheter (US Catheter and Instrument Co) was placed via the jugular vein into the inferior vena cava under fluoroscopic guidance and inflated to decrease ventricular preload. LV pressure and stroke volume were measured over the subsequent 10 beats, and stroke work was plotted against left ventricular end diastolic pressure (LVEDP).18 The relationship was plotted for all 10 beats; correlation coefficients were calculated; all were >0.94, and most were 0.99. Caval occlusions were repeated 5 times, and mean slopes were recorded.

End-Systolic Elastance
End-systolic elastance (Ees) was measured by use of an occlusive balloon in the ascending aorta as previously described and validated.19 A custom-made 50-mL intra-aortic balloon (Datascope, Inc) was placed during fluoroscopy in the aortic root from the femoral artery and was connected to a System 90-T intra-aortic balloon pump (Datascope Inc). The balloon was triggered to inflate during diastole and to remain inflated during the following contraction. The balloon produced an isovolumic contraction (verified by flow probe). Using custom software, we constructed a pair of pressure-volume relationships from simultaneous pressure and flow tracings of the last ejecting and first isovolumic contraction19 and assumed no change in end-diastolic volume.19 The end-systolic pressure-volume relationship (ESPVR) or Ees was drawn from the peak isovolumic pressure-volume point tangential to the left upper corner of the pressure-volume loop of the ejecting contraction. Balloon inflation was repeated 5 times; absolute LV volume was not measured.

Ees values obtained from 2 pressure-volume relationships (nonoccluded and completely occluded) were compared with mean values obtained from families of 4 partially occlusive pressure-volume loops created by varying volume in the ascending aortic balloon for 6 sheep at baseline and 2 sheep throughout the entire 8-week study (n=14). Results showed that average Ees values obtained by both methods differed by 3.4±1.3%, and slopes were not significantly different by paired t test (P=0.69). Thereafter, all Ees measurements were made by the complete occlusion method described above.

Infarction
After baseline data had been obtained, the previously placed exteriorized subcutaneous snares were tightened sequentially. Arrhythmias were rigorously monitored and controlled by an infusion of lidocaine 2 mg/min and bolus doses of bretylium 5 mg/kg and magnesium 0.5 g before infarction and esmolol 0.5 to 2.0 mg/kg after infarction. When hemodynamic measurements stabilized ({approx}1 hour), postinfarction measurements were made. The laparotomy was closed.

Follow-Up Studies
Identical measurements were made at 1, 2, 5, and 8 weeks after infarction. Only 9 measurements (5 mesh, 4 controls) were made at 1 week; all surviving sheep had measurements at the other time intervals. After week 8, the animal was euthanized (potassium chloride 80 mEq). The heart was excised, and the LV was opened in the long axis and photographed. Sections were taken for histology.

Statistics
Measurements are reported as mean±SD. Differences between groups are compared by 2-way MANOVA (group, time) with Bonferroni adjustment for repeated measures (SPSS 6.0). When the group effect is significant, 1-way ANOVA is used to determine significant differences at different times in each group separately. If the time effect is significant by 1-way ANOVA, differences between before-infarction measurements and measurements at subsequent times are compared by the paired t statistic. When the group effect is significant, differences between groups at specific times are compared by the unpaired t statistic. Significance is accepted at the P<0.05 probability.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Fifteen sheep (9 control, 6 mesh) completed the 8-week protocol. Two animals in the control group died early after infarction, and 2 in group 2 died between 2 and 5 weeks of arrhythmias. Four sheep in group 2 died after 4 weeks of pneumonia, embolic stroke, or euthanasia for wound complications.2 At week 8, all control animals had evidence of heart failure (rales, lethargy); no mesh animal had evidence of heart failure.

Histological sections of mesh-covered infarcts 2 and 8 weeks after infarction show a nonspecific fibrous reaction surrounding mesh fibers without new vessel ingrowth (Figure 1Down). The epicardial fibrotic reaction does not progress after 2 weeks (Figure 1Down).



View larger version (101K):
[in this window]
[in a new window]
 
Figure 1. A, Hematoxylin-eosin (H&E)–stained, low-power micrograph of a mesh-treated animal 2 weeks after infarction. Mesh (empty spaces) is surrounded by a vigorous fibrotic reaction. B, Low-power H&E stain of mesh-treated infarct 8 weeks after infarction. C, High-power view at 8 weeks showing fibrous tissue surrounding mesh and a single giant cell. There is no evidence of collateral blood vessel ingrowth.

Echocardiograms in sheep with mesh show normal wall thickness and systolic wall thickening beneath the mesh before infarction. Diastolic wall thickness is similar in both groups (8.9±0.3 [SEM] mm, mesh; 9.2±0.4 mm, control) (P=0.47). At week 8, wall thickness near the infarcted apex was 4.8±0.3 (SEM) mm in group 1 and 6.6±0.2 mm in group 2 sheep (P=0.0004).

Hemodynamic measurements are presented in Table 1Down. The data indicate progressive deterioration in circulatory function over 8 weeks in group 1 sheep and no significant changes in resting hemodynamics in group 2 sheep except immediately after infarction (Figure 2Down, Table 1Down).


View this table:
[in this window]
[in a new window]
 
Table 1. Mean±SD of Measured Hemodynamic Parameters



View larger version (16K):
[in this window]
[in a new window]
 
Figure 2. LV end-diastolic pressure for control ({circ}) and mesh-treated ({bullet}) sheep at each time point. Error bars represent SEM. *P<0.05; {dagger}P<0.01 by unpaired t test between groups.

LV end-diastolic and end-systolic volumes increase progressively over 8 weeks in control sheep but do not progress after week 1 postinfarction in mesh-treated sheep (Figure 3Down). At week 8, end-systolic and end-diastolic volumes are significantly smaller in sheep with restrained infarcts (Table 2Down).



View larger version (22K):
[in this window]
[in a new window]
 
Figure 3. End-diastolic ({circ}, {bullet}) and end-systolic ({triangleup}, {blacktriangleup}) volumes for control and mesh-treated animals at each time point.

{ddagger}P<0.01 within groups vs baseline value. Other symbols as in Figure 2Up.


View this table:
[in this window]
[in a new window]
 
Table 2. Mean±SD of Measured and Calculated Parameters

In control sheep, ejection fraction, stroke volume, stroke work, the stroke work–LVEDP relationship, and Ees and stroke volume progressively decrease after infarction, and all values except Ees are significantly less than preinfarction measurements at week 8 (Figure 4Down, Table 2Up). In group 2 sheep, stroke volume, stroke work, the stroke work–LVEDP relationship, and Ees do not differ significantly from baseline measurements at any time after infarction. Ejection fraction decreases early after infarction but does not decrease further after the first week (Table 2Up).



View larger version (16K):
[in this window]
[in a new window]
 
Figure 4. Stroke work for control and mesh-treated animals at each time point. Symbols as in Figure 2Up.

Figures 5Down and 6Down illustrate long-axis echocardiograms before infarction and at 1 and 8 weeks after infarction in control and mesh-treated sheep. The mesh-restrained infarct does not expand, whereas the unrestrained infarct expands asymmetrically into an anteroapical aneurysm.



View larger version (74K):
[in this window]
[in a new window]
 
Figure 5. A, Long-axis echocardiogram at end systole before infarction; B, 1 week after infarction; and C, 8 weeks after infarction in a control sheep. Arrows and arrowheads mark junctions between dyskinetic segment and contracting myocardium on anterior wall (arrow) and posterior wall (arrowhead). LA indicates left atrium; LV, left ventricle.



View larger version (72K):
[in this window]
[in a new window]
 
Figure 6. A, Long-axis echocardiogram at end systole before infarction; B, 1 week after infarction; and C, 8 weeks after infarction in a mesh-treated sheep. Arrows, arrowheads, and abbreviations as in Figure 5Up.

MANOVA with adjustment for repeated measures showed a significant time effect (P<0.05) for 25 of 34 echocardiographic variables measured; however, only 5 variables were significantly different between groups when analyzed without baseline measurements (Table 3Down). Differences in LV diastolic cavity shape between groups approached statistical significance at 8 weeks (P=0.055) (Table 3Down). In mesh-treated sheep, infarct expansion was less over time in control animals and the contractile segment of the anterior wall was greater (Table 3Down).


View this table:
[in this window]
[in a new window]
 
Table 3. P Values Within Groups Calculated by One-Way ANOVA

Figure 7Down is a photograph of a normal ovine heart, a mesh-constrained anteroapical infarction, and an untreated anteroapical infarction at week 8. The shapes of the mesh-constrained infarcted heart and the uninfarcted normal heart are similar.



View larger version (69K):
[in this window]
[in a new window]
 
Figure 7. Photograph of longitudinally cut left ventricles of A, Normal sheep; B, Mesh-treated infarcted sheep; and C, Control infarcted sheep.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
A patch of Marlex mesh applied before infarction overcomes the technical obstacle of restraining infarct expansion. The ensuing fibrosis prevents infarct expansion, does not change baseline wall thickness, and has minimal impact on surrounding myocardium. Consistency of ovine coronary arterial anatomy between sheep and lack of preformed collateral vessels20 permit accurate prediction of infarct size and location.16 Although the method has no therapeutic value, mesh permits a test of our hypothesis.

Prevention of infarct expansion attenuates a decrease in ejection fraction, prevents aneurysm formation, and preserves resting ventricular function. The ventricle retains its normal conical shape despite loss of 0.23 of LV mass.16 In the mesh group, dimensional, hemodynamic, and functional consequences of the infarct do not progress after 1 or 2 weeks. Exercise reserve may be reduced, but resting ventricular geometry and function are preserved and progressive ventricular deformation is aborted.

Expanding acute anterior infarctions produce progressive deterioration in ventricular function, dilatation, and eventually heart failure in both patients and sheep.1 3 9 10 11 16 The sheep model may exaggerate and accelerate this scenario, but in both species, there is little evidence that either the size or function of the ventricle stabilizes or that the remodeling process ends until regional expansion ends.10 11 16 21

The progressive deterioration in ventricular function is best explained by ongoing involvement of viable, border-zone myocardium. Ischemia rapidly reduces end-systolic wall thickness22 and, by LaPlace's law, increases end-systolic circumferential and meridional wall stresses. Increased regional wall stresses favor infarct expansion, but the amount of expansion also depends on material properties of the new infarction. If the infarct expands, the radius of curvature of infarct and adjacent border zone also increases15; elevated wall stresses in both regions cause progressive wall thinning. Border-zone thinning decreases myocyte contractility,23 increases segmental length, and pulls myocardium toward the expanding infarct. Mature scar may stabilize the center of the infarct,15 but in the border zone, the process may continue until expansion stops or heart failure and death intervene.

Material properties of the normal, beating heart are heterogeneous, anisotropic, and time-dependent and are affected by numerous variables, including alignment of layered collagen and muscle fibers.24 The material properties of myocardial infarctions are also heterogeneous, anisotropic, and possibly even time-dependent.12 25 Compliance of the infarct initially decreases after infarction because of edema and necrotic myocytes12 26 but often increases later.2 15 27 Late changes in infarct compliance vary with infarct size, location, transmurality, and other factors2 3 7 11 and reflect changes in infarct material properties and regional wall stresses in the remodeling ventricle.2 3 7 11 15 In sheep28 and perhaps in humans, differences in infarct expansion between anterior and posterior infarctions of similar sizes may be explained by differences in material properties rather than initial differences in systolic wall stress. Stable ventricular geometry requires a balance between myocardial material properties resisting expansion and ventricular wall stresses and strains. It follows that when regional wall stresses increase, myocardium must either stiffen to prevent or minimize strain or, alternatively, deform in the direction of applied stresses.

The clinical benefit of preventing infarct deformation and preserving ventricular geometry shown in this study focuses attention on the extracellular matrix of healing infarctions.29 Late reperfusion (6 to 12 hours after onset of chest pain) attenuates infarct expansion and improves survival but does not rescue myocytes.5 30 Initially, hemorrhage and edema may stiffen the infarct; later, revascularization may alter the molecular and cellular responses in the extracellular matrix. At present, no surgical procedures exist to limit expansion of acute infarctions, but given the need, operations can be developed.

Limitations of This Study
The relevance of the sheep model to transmural anteroapical infarctions in humans cautions against extrapolation of these conclusions to patients. The sheep model avoids many confounding variables associated with human anteroseptal infarctions, but these variables may be relevant to clinical care.

Mesh applied before infarction may stimulate an inflammatory reaction within the underlying myocardium and alter the remodeling process independently of external restraint. At this time, this possibility lacks supportive evidence. It is acknowledged that the mesh also covered some border-zone tissue, but the amount is small and logically should reduce rather than enhance LV performance.

This study raises but does not address the issue of how best to prevent expansion of acute myocardial infarctions.


*    Acknowledgments
 
This study was supported by grant HL-36308 from the NHLBI, NIH, Bethesda, Md. The authors thank Priscilla Hillyer and Dr Carol Reynolds for their help in this study.

Received March 27, 1998; revision received August 21, 1998; accepted August 31, 1998.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Eaton LW, Weiss JL, Bulkley Eaton BH, Garrison JB, Weisfeldt ML. Regional cardiac dilation after acute myocardial infarction. N Engl J Med. 1979;300:57–62.[Abstract]

2. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: experimental observations and clinical implications. Circulation. 1990;81:1161–1172.[Abstract/Free Full Text]

3. McKay RG, Pfeffer MA, Pasternak RC, Markis JE, Come PC, Nakao S, Alderman JD, Ferguson JJ, Safian RD, Grossman W. Left ventricular remodeling after myocardial infarction: a corollary to infarct expansion. Circulation. 1986;74:693–702.[Abstract/Free Full Text]

4. Meizlisch JL, Berger HJ, Plankey M, Errico D, Levy W, Zaret BL. Functional left ventricular aneurysm formation after acute anterior transmural myocardial infarction: Incidence, natural history and prognostic implications N Engl J Med. 1984; 311:1001–1006.

5. Kim C, Braunwald E. Potential benefits of late reperfusion of infarcted myocardium: the open artery hypothesis. Circulation. 1993;88:2426–2436.[Free Full Text]

6. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting enzyme inhibition. Lancet. 1991;337:872–876.[Medline] [Order article via Infotrieve]

7. Stone PH, Raabe DS, Jaffe AS, Gustafson N, Muller JE, Turi ZG, Rutherford JD, Poole WK, Passamani E, Willerson JT, Sobel BE, Robertson T, Braunwald E, for the MILIS Group. Prognostic significance of location and type of myocardial infarction: independent adverse outcome associated with anterior location. J Am Coll Cardiol. 1988;11:453–463.[Abstract]

8. Olivetti G, Capasso JM, Sonnenblick EH, Anversa P. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. Circ Res. 1990;67:23–34.[Abstract/Free Full Text]

9. St John Sutton M, Pfeffer MA, Plappert T, Rouleau J-L, Moyé LW, Dagenais GR, Lamas GA, Klein M, Sussex B, Goldman S, Menapace FJ Jr, Parker JO, Lewis S, Sestier F, Gordon DF, McEwan P, Bernstein V, Braunwald E, for the SAVE Investigators. Quantitative two-dimensional echocardiographic measurements are major predictors of adverse cardiovascular events after acute myocardial infarction Circulation. 1994;89:68–75.[Abstract/Free Full Text]

10. St John Sutton MG, Pfeffer MA, Moye L, Plappert T, Rouleau JL, Lamas G, Rouleau J, Parker JO, Arnold MO, Sussex B, Braunwald E, for the SAVE Investigators. Cardiovascular death and left ventricular remodeling two years after myocardial infarction. Circulation. 1997;96:3294–3299.[Abstract/Free Full Text]

11. Gaudron P, Eilles C, Kugler I, Ertl G. Progressive left ventricular dysfunction and remodeling after myocardial infarction: potential mechanisms and early predictors. Circulation. 1993;87:755–763.[Abstract/Free Full Text]

12. Gupta KB, Ratcliffe MB, George DT, Fallert MA, Edmunds LH Jr, Bogen DK. Passive biaxial stiffness on the LV wall after anteroapical infarction: changes during aneurysm formation. Circulation. 1994;89:2315–2326.[Abstract/Free Full Text]

13. Bogen DK, Rabinowitz SA, Needleman A, McMahon TA, Abelmann WH. An analysis of the mechanical disadvantage of myocardial infarction in the canine left ventricle. Circ Res. 1980;47:728–741.[Abstract/Free Full Text]

14. Janz RF, Waldron RJ. Predicted effect of chronic apical aneurysms on the passive stiffness of the human left ventricle. Circ Res. 1978;42:255–263.[Free Full Text]

15. Connelly CM, McLaughlin RJ, Vogel WM, Apstein CS. Reversible and irreversible elongation of ischemic infarcted and healed myocardium in response to increases in preload and afterload. Circulation. 1991;84:387–399.[Abstract/Free Full Text]

16. Markovitz LJ, Savage EB, Ratcliffe MB, Bavaria JE, Kreimer G, Iozzo RV, Hargrove WC, Bogen DK, Edmunds LH Jr. Large animal model of left ventricular aneurysm. Ann Thorac Surg. 1989;48:838–845.[Abstract]

17. Schiller NB, Shah PM, Crawford M, DeMaria AN, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Sahn D, Schnitter I, Silverman MH, Tajik J. Recommendation for the quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;5:358–362.

18. Nicolosi AC, Weng Z-C, Detwiler PW, Spotnitz HM. Simulated left ventricular aneurysm and aneurysm repair in swine. J Thorac Cardiovasc Surg. 1990;100:745–755.[Abstract]

19. Gupta KB, Bavaria JE, Ratcliffe MB, Edmunds LH Jr, Bogen DK. Measurement of end-systolic pressure-volume relations by intra-aortic balloon occlusion Circulation. 1989;80:1016–1028.[Abstract/Free Full Text]

20. Vaslesaeger MM, Van Der Straeten PP, Friart J, Candaele G, Ghys A, Bernard RM. Les anastomoses intercoronariennes telles qu'elles apparaissent a la coronarographie post mortem. Acta Cardiol. 1957;12:365–401.[Medline] [Order article via Infotrieve]

21. Willems IEMG, Havenith MG, De May JGR, Daemaen MJAP. The {alpha}-smooth muscle actin-positive cells in healing human myocardial scars. Am J Pathol. 1994;145:868–875.[Abstract]

22. Heyndrickx GR, Amano J, Patrick TA, Manders WT, Rogers GG, Rosendorff C, Vatner SF. Effects of coronary artery reperfusion on regional myocardial blood flow and function in conscious baboons. Circulation. 1985;71:1029–1037.[Abstract/Free Full Text]

23. Gallagher KP, Gerren RA, Stirling MC, Choy M, Dysko RC, McManimon SP, Dunham WR. The distribution of functional impairment across the lateral border of acutely ischemic myocardium. Circ Res. 1986;58:570–583.[Abstract/Free Full Text]

24. McCulloch AD, Guccione JM, Waldman LK, Rogers JM. Large-scale finite element analysis of the beating heart. Crit Rev Biomed Eng. 1992;20:427–449.[Medline] [Order article via Infotrieve]

25. Whitaker P, Boughner DR, Kloner RA. Analysis of healing after myocardial infarction using polarized light microscopy. Am J Pathol. 1989;134:879–893.[Abstract]

26. Vogel WM, Apstein CS, Briggs LL, Gaasch WH, Ahn J. Acute alterations in left ventricular diastolic chamber stiffness. Circ Res. 1982;51:465–478.[Free Full Text]

27. Vokonas PS, Pirzada FA, Hood WB. Experimental myocardial infarction, XII: dynamic changes in segmental mechanical behavior of infarcted and non infarcted myocardium. Am J Cardiol. 1976;37:853–859.[Medline] [Order article via Infotrieve]

28. Gorman JH III, Gorman RC, Plappert T, Jackson BM, Hiramatsu Y, St John Sutton MG, Edmunds LH Jr. Infarct size and location determine development of mitral regurgitation in the sheep model. J Thorac Cardiovasc Surg. 1998;115:615–622.[Abstract/Free Full Text]

29. Weber KT. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation. 1997;96:4065–4082.[Free Full Text]

30. Nidorf SM, Siu SC, Galambos G, Weyman AE, Picard MH. Benefit of late coronary reperfusion on ventricular morphology and function after myocardial infarction. J Am Coll Cardiol. 1993;21:683–691.[Abstract]




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
J. J. Pilla, J. H. Gorman III, and R. C. Gorman
Theoretic impact of infarct compliance on left ventricular function.
Ann. Thorac. Surg., March 1, 2009; 87(3): 803 - 810.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
L. P. Ryan, K. Matsuzaki, M. Noma, B. M. Jackson, T. J. Eperjesi, T. J. Plappert, M. G. St. John-Sutton, J. H. Gorman III, and R. C. Gorman
Dermal Filler Injection: A Novel Approach for Limiting Infarct Expansion
Ann. Thorac. Surg., January 1, 2009; 87(1): 148 - 155.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. Mukherjee, J. A. Zavadzkas, S. M. Saunders, J. E. McLean, L. B. Jeffords, C. Beck, R. E. Stroud, A. M. Leone, C. N. Koval, W. T. Rivers, et al.
Targeted Myocardial Microinjections of a Biocomposite Material Reduces Infarct Expansion in Pigs
Ann. Thorac. Surg., October 1, 2008; 86(4): 1268 - 1276.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Beeri, C. Yosefy, J. L. Guerrero, F. Nesta, S. Abedat, M. Chaput, F. del Monte, M. D. Handschumacher, R. Stroud, S. Sullivan, et al.
Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation.
J. Am. Coll. Cardiol., January 29, 2008; 51(4): 476 - 486.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. S. Blom, J. J. Pilla, J. Arkles, L. Dougherty, L. P. Ryan, J. H. Gorman III, M. A. Acker, and R. C. Gorman
Ventricular Restraint Prevents Infarct Expansion and Improves Borderzone Function After Myocardial Infarction: A Study Using Magnetic Resonance Imaging, Three-Dimensional Surface Modeling, and Myocardial Tagging
Ann. Thorac. Surg., December 1, 2007; 84(6): 2004 - 2010.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
H. Sakamoto, L. M. Parish, H. Hamamoto, L. P. Ryan, T. J. Eperjesi, T. J. Plappert, B. M. Jackson, M. G. St John-Sutton, J. H. Gorman III, and R. C. Gorman
Effect of Reperfusion on Left Ventricular Regional Remodeling Strains After Myocardial Infarction
Ann. Thorac. Surg., November 1, 2007; 84(5): 1528 - 1536.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Hung, M. Chaput, J. L. Guerrero, M. D. Handschumacher, L. Papakostas, S. Sullivan, J. Solis, and R. A. Levine
Persistent Reduction of Ischemic Mitral Regurgitation by Papillary Muscle Repositioning: Structural Stabilization of the Papillary Muscle Ventricular Wall Complex
Circulation, September 11, 2007; 116(11_suppl): I-259 - I-263.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. Langer, F. Rodriguez, A. Cheng, S. Ortiz, K. B. Harrington, M. K. Zasio, G. T. Daughters, J. C. Criscione, N. B. Ingels, and D. C. Miller
Alterations in Lateral Left Ventricular Wall Transmural Strains During Acute Circumflex and Anterior Descending Coronary Occlusion
Ann. Thorac. Surg., July 1, 2007; 84(1): 51 - 60.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. L. Christman and R. J. Lee
Biomaterials for the Treatment of Myocardial Infarction
J. Am. Coll. Cardiol., September 5, 2006; 48(5): 907 - 913.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Yano, T. Miura, P. Whittaker, T. Miki, J. Sakamoto, Y. Nakamura, Y. Ichikawa, Y. Ikeda, H. Kobayashi, K. Ohori, et al.
Macrophage Colony-Stimulating Factor Treatment After Myocardial Infarction Attenuates Left Ventricular Dysfunction by Accelerating Infarct Repair
J. Am. Coll. Cardiol., February 7, 2006; 47(3): 626 - 634.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
B. M. Jackson, L. M. Parish, J. H. Gorman III, Y. Enomoto, H. Sakamoto, T. Plappert, M. G. St. John Sutton, I. Salgo, and R. C. Gorman
Borderzone Geometry After Acute Myocardial Infarction: A Three-Dimensional Contrast Enhanced Echocardiographic Study
Ann. Thorac. Surg., December 1, 2005; 80(6): 2250 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. J. Pilla, A. S. Blom, J. H. Gorman III, D. J. Brockman, J. Affuso, L. M. Parish, H. Sakamoto, B. M. Jackson, M. A. Acker, and R. C. Gorman
Early Postinfarction Ventricular Restraint Improves Borderzone Wall Thickening Dynamics During Remodeling
Ann. Thorac. Surg., December 1, 2005; 80(6): 2257 - 2262.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
I. A. Memon, Y. Sawa, N. Fukushima, G. Matsumiya, S. Miyagawa, S. Taketani, S. K. Sakakida, H. Kondoh, A. N. Aleshin, T. Shimizu, et al.
Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets
J. Thorac. Cardiovasc. Surg., November 1, 2005; 130(5): 1333 - 1341.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Levine and E. Schwammenthal
Ischemic Mitral Regurgitation on the Threshold of a Solution: From Paradoxes to Unifying Concepts
Circulation, August 2, 2005; 112(5): 745 - 758.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Rodriguez, F. Langer, K. B. Harrington, A. Cheng, G. T. Daughters, J. C. Criscione, N. B. Ingels, and D. C. Miller
Alterations in transmural strains adjacent to ischemic myocardium during acute midcircumflex occlusion
J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 791 - 803.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
Y. Enomoto, J. H. Gorman III, S. L. Moainie, B. M. Jackson, L. M. Parish, T. Plappert, A. Zeeshan, M. G. St. John-Sutton, and R. C. Gorman
Early Ventricular Restraint After Myocardial Infarction: Extent of the Wrap Determines the Outcome of Remodeling
Ann. Thorac. Surg., March 1, 2005; 79(3): 881 - 887.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
Y. Enomoto, J. H. Gorman III, S. L. Moainie, T. S. Guy, B. M. Jackson, L. M. Parish, T. Plappert, A. Zeeshan, M. G. St. John-Sutton, and R. C. Gorman
Surgical treatment of ischemic mitral regurgitation might not influence ventricular remodeling
J. Thorac. Cardiovasc. Surg., March 1, 2005; 129(3): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Cirillo, A. Amaducci, F. Brunelli, M. Dalla Tomba, P. Parrella, G. Tasca, G. Troise, and E. Quaini
Determinants of postinfarction remodeling affect outcome and left ventricular geometry after surgical treatment of ischemic cardiomyopathy
J. Thorac. Cardiovasc. Surg., June 1, 2004; 127(6): 1648 - 1656.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. S. Guy IV, S. L. Moainie, J. H. Gorman III, B. M. Jackson, T. Plappert, Y. Enomoto, M. G. St. John-Sutton, L. H. Edmunds Jr, and R. C. Gorman
Prevention of ischemic mitral regurgitation does not influence the outcome of remodeling after posterolateral myocardial infarction
J. Am. Coll. Cardiol., February 4, 2004; 43(3): 377 - 383.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Gorman III, B. M. Jackson, Y. Enomoto, and R. C. Gorman
The effect of regional ischemia on mitral valve annular saddle shape
Ann. Thorac. Surg., February 1, 2004; 77(2): 544 - 548.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. H. Gorman III, R. C. Gorman, B. M. Jackson, Y. Enomoto, M. G. St. John-Sutton, and L. H. Edmunds Jr
Annuloplasty ring selection for chronic ischemic mitral regurgitation: lessons from the ovine model
Ann. Thorac. Surg., November 1, 2003; 76(5): 1556 - 1563.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. J. Villarreal, M. Griffin, J. Omens, W. Dillmann, J. Nguyen, and J. Covell
Early Short-Term Treatment With Doxycycline Modulates Postinfarction Left Ventricular Remodeling
Circulation, September 23, 2003; 108(12): 1487 - 1492.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Matsubayashi, P. W.M. Fedak, D. A.G. Mickle, R. D. Weisel, T. Ozawa, and R.-K. Li
Improved Left Ventricular Aneurysm Repair With Bioengineered Vascular Smooth Muscle Grafts
Circulation, September 9, 2003; 108(90101): II-219 - 225.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. M. Jackson, J. H. Gorman III, I. S. Salgo, S. L. Moainie, T. Plappert, M. St. John-Sutton, L. H. Edmunds Jr., and R. C. Gorman
Border zone geometry increases wall stress after myocardial infarction: contrast echocardiographic assessment
Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H475 - H479.
[Abstract] [Full Text] [PDF]


Home page
Card Surg AdultHome page
R. C. Gorman, J. H. Gorman III, and L. H. Edmunds Jr.
Ischemic Mitral Regurgitation
Card. Surg. Adult, January 1, 2003; 2(2003): 751 - 769.
[Full Text]


Home page
J Am Coll CardiolHome page
B. M. Jackson, J. H. Gorman III, S. L. Moainie, T. S. Guy, N. Narula, J. Narula, M. G. St. John-Sutton, L. H. Edmunds Jr, and R. C. Gorman
Extension of borderzone myocardium in postinfarction dilated cardiomyopathy
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1160 - 1167.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. B. Ratcliffe
Non-ischemic infarct extension: A new type of infarct enlargement and a potential therapeutic target
J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1168 - 1171.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
S. L. Moainie, T. S. Guy, J. H. Gorman III, T. Plappert, B. M. Jackson, M. G. St. John-Sutton, L. H. Edmunds Jr, and R. C. Gorman
Infarct restraint attenuates remodeling and reduces chronic ischemic mitral regurgitation after postero-lateral infarction
Ann. Thorac. Surg., August 1, 2002; 74(2): 444 - 449.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. C. Gorman and J. H. Gorman III
Cellular myoplasty: What are we really trying to achieve?
J. Thorac. Cardiovasc. Surg., March 1, 2002; 123(3): 582 - 583.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
R. C. Gorman and J. H. Gorman III
Cellular myoplasty: what are we really trying to achieve?
Ann. Thorac. Surg., January 1, 2002; 73(1): 342 - 343.
[Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. W. Bowen, S. C. Jones, N. Narula, M. G. St. John Sutton, T. Plappert, L. H. Edmunds Jr, and I. M.C. Dixon
Restraining acute infarct expansion decreases collagenase activity in borderzone myocardium
Ann. Thorac. Surg., December 1, 2001; 72(6): 1950 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
F. W. Bowen, T. Hattori, N. Narula, I. S. Salgo, T. Plappert, M. G. St. John Sutton, and L. H. Edmunds Jr
Reappearance of myocytes in ovine infarcts produced by six hours of complete ischemia followed by reperfusion
Ann. Thorac. Surg., June 1, 2001; 71(6): 1845 - 1855.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Jain, H. DerSimonian, D. A. Brenner, S. Ngoy, P. Teller, A. S. B. Edge, A. Zawadzka, K. Wetzel, D. B. Sawyer, W. S. Colucci, et al.
Cell Therapy Attenuates Deleterious Ventricular Remodeling and Improves Cardiac Performance After Myocardial Infarction
Circulation, April 10, 2001; 103(14): 1920 - 1927.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Q.-G. Xia, O. Chung, H. Spitznagel, S. Illner, G. Janichen, B. Rossius, P. Gohlke, and T. Unger
Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure
Cardiovasc Res, January 1, 2001; 49(1): 110 - 117.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J. Edwards, M. S. Marber, S. T. Kelley, R. Malekan, J. H. Gorman III, B. M. Jackson, R. C. Gorman, Y. Suzuki, T. Plappert, D. K. Bogen, et al.
Restraining Infarct Expansion Preserves Left Ventricular Geometry and Function After Acute Anteroapical Infarction • Response
Circulation, December 21, 1999; 100 (25): e152 - e152.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kelley, S. T.
Right arrow Articles by Edmunds, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kelley, S. T.
Right arrow Articles by Edmunds, L. H., Jr
Related Collections
Right arrow Remodeling
Right arrow Animal models of human disease
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Acute myocardial infarction